Cowen Healthcare Investments

Cowen Healthcare Investments (CHI) operates as the dedicated private equity arm of TD Cowen, a prominent financial services firm. Based in New York, United States, CHI specializes in providing growth capital to private healthcare companies. The firm's investment strategy is deeply rooted in identifying and supporting innovative businesses within the biotechnology, pharmaceutical, medical device, diagnostics, and healthcare services sectors. Their focus is primarily on companies that are either commercial-stage or nearing commercialization, possessing products or services designed to address significant unmet medical needs.

CHI distinguishes itself by targeting late-stage private companies that require capital for critical growth initiatives, such as product launches, market expansion, or strategic acquisitions. They seek out businesses with proven technologies and strong management teams, aiming to accelerate their trajectory towards market leadership. The firm leverages the extensive healthcare expertise and network of its parent company, TD Cowen, including its robust investment banking, research, and sales & trading capabilities, to provide portfolio companies with strategic guidance and industry insights beyond just capital.

Typically, Cowen Healthcare Investments deploys first cheques ranging from $10 million to $50 million, often participating in or leading significant funding rounds. This flexible approach allows them to support a diverse range of growth opportunities within the healthcare landscape. Their commitment to the sector is further evidenced by their successful fundraising efforts, with their most recent fund, Cowen Healthcare Investments V, closing at $425 million in 2023. This substantial capital base enables them to make meaningful investments and provide sustained support to their portfolio companies as they scale and bring vital healthcare solutions to market.